1 reports of this reaction
2.0% of all CHILDRENS PAIN RELIEF reports
#10 most reported adverse reaction
CATHETER SITE INFECTION is the #10 most commonly reported adverse reaction for CHILDRENS PAIN RELIEF, manufactured by Allegiant Health. There are 1 FDA adverse event reports linking CHILDRENS PAIN RELIEF to CATHETER SITE INFECTION. This represents approximately 2.0% of all 50 adverse event reports for this drug.
Patients taking CHILDRENS PAIN RELIEF who experience catheter site infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CATHETER SITE INFECTION is a less commonly reported adverse event for CHILDRENS PAIN RELIEF, but still significant enough to appear in the safety profile.
In addition to catheter site infection, the following adverse reactions have been reported for CHILDRENS PAIN RELIEF:
The following drugs have also been linked to catheter site infection in FDA adverse event reports:
CATHETER SITE INFECTION has been reported as an adverse event in 1 FDA reports for CHILDRENS PAIN RELIEF. This does not prove causation, but indicates an association observed in post-market surveillance data.
CATHETER SITE INFECTION accounts for approximately 2.0% of all adverse event reports for CHILDRENS PAIN RELIEF, making it a notable side effect.
If you experience catheter site infection while taking CHILDRENS PAIN RELIEF, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.